Adam J. Rose, MD, MSc

home / authors / adam-j-rose-md-msc

Articles

March 8th 2019

Gender Differences in Prescribing of Zolpidem in the Veterans Health Administration

Guneet K. Jasuja, PhD Joel I. Reisman, AB Renda Soylemez Wiener, MD, MPH Melissa L. Christopher, PharmD Adam J. Rose, MD, MSc

We found inappropriate prescribing of zolpidem, in terms of both guideline-discordant dosage and coprescribing with benzodiazepines, with female veterans affected more than male veterans.

November 16th 2018

Overdose Risk for Veterans Receiving Opioids From Multiple Sources

Guneet K. Jasuja, PhD Omid Ameli, MD, MPH Donald R. Miller, ScD Thomas Land, PhD Dana Bernson, MPH Adam J. Rose, MD, MSc Dan R. Berlowitz, MD, MPH David A. Smelson, PsyD

Among veterans in Massachusetts, receipt of opioids from multiple sources, with or without benzodiazepines, was associated with worse opioid-related outcomes.

January 20th 2016

Does Distance Modify the Effect of Self-Testing in Oral Anticoagulation?

Adam J. Rose, MD, MSc Ciaran S. Phibbs, PhD Lauren Uyeda, MA Pon Su, MS Robert Edson, MA Mei-Chiung Shih, PhD Alan Jacobson, MD David B. Matchar, MD

Self-testing of anticoagulation improves outcomes, but is expensive. One might assume it is more helpful for patients living farther from care, but the authors disprove this assumption.

April 19th 2011

Relevance of Current Guidelines for Organizing an Anticoagulation Clinic

Adam J. Rose, MD, MSc Elaine M. Hylek, MD, MPH Al Ozonoff, PhD Arlene S. Ash, PhD Joel I. Reisman, AB Patricia P. Callahan, RPh Margaret M. Gordon, PharmD Dan R. Berlowitz, MD, MPH

Anticoagulation clinics in an integrated healthcare system differed widely in their organization and management, but these differences were not consistently related to their performance.

April 2nd 2009

Does Opioid Therapy Affect Quality of Care for Diabetes Mellitus?

Adam J. Rose, MD, MSc John A. Hermos, MD Susan M. Frayne, MD, MPH Leonard M. Pogach, MD, MBA Dan R. Berlowitz, MD, MPH Donald R. Miller, ScD

Within the Veterans Affairs system, diabetes performance measures were similar in patients who received chronic opioid therapy and in those who did not.